Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Characterization of a new illicit phosphodiesterase-type-5 inhibitor identified in the softgel shell of a dietary supplement
Ist Teil von
Journal of pharmaceutical and biomedical analysis, 2018-11, Vol.161, p.61-65
Ort / Verlag
England: Elsevier B.V
Erscheinungsjahr
2018
Quelle
MEDLINE
Beschreibungen/Notizen
[Display omitted]
•A novel sildenafil analog found from a dietary supplement was investigated by UV spectroscopy and high-resolution MS analysis.•We synthesized propoxyphenyl noracetildenafil as the reference standard.•The illicit sildenafil analogs were mainly detected from the shell of the capsule sample.
A new sildenafil analog has been identified in the softgel shell of a dietary supplement. The compound was investigated by UV spectroscopy and high-resolution MS analysis, leading to the proposed structure 1-methyl-5-{5-[2-(4-methylpiperazin-1-yl)acetyl]-2-propoxyphenyl}-3-propyl-1,6-dihydro-7H-pyrazolo[4,3-d]pyrimidin-7-one. A synthetic reference compound with the proposed structure was prepared, and the two sets of analytical data were compared, confirming the structure of the new compound. The compound was named propoxyphenyl noracetildenafil from its structure and similarity with the known compound.